From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson's Disease.

MLA

“From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson’s Disease.” Medicinal Chemistry Approaches to Personalized Medicine, Jan. 2013, pp. 227–54. EBSCOhost, https://doi.org/10.1002/9783527677252.ch10.

APA

From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson’s Disease. (2013). Medicinal Chemistry Approaches to Personalized Medicine, 227–254. https://doi.org/10.1002/9783527677252.ch10

Chicago

“From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson’s Disease.” 2013. Medicinal Chemistry Approaches to Personalized Medicine, January, 227–54. doi:10.1002/9783527677252.ch10.